DATE: July 28, 2020
TIME: 9:00 am PDT, 12:00 pm EDT
The demographic profile of hepatitis B and C has seen a paradigm shift over the last 10 years and as a result clinical guidelines for hepatitis testing are changing. With updated screening recommendations on the way it is necessary to understand the role of serological markers in both diagnosis of hepatitis B virus (HBV) and monitoring HBV disease status. The best way to reduce the spread of HBV infection and to optimize patient management is through the implementation of robust serological testing; with a few caveats along the way.
Learning Objectives:
-
Understand the shift in screening recommendation for hepatitis in the clinical guidelines based on the rise of hepatitis in younger demographics including HBV and HCV
-
Recognize the importance of serological markers for HBV diagnosis and management
-
Identify potential caveats when testing based on serological profiles and the complexity of HBV
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.